1
|
Lan Z, Fletcher A, Bender EC, Huang W, Suggs LJ, Cosgriff-Hernandez E. Hydrogel foam dressings with angiogenic and immunomodulatory factors from mesenchymal stem cells. J Biomed Mater Res A 2024; 112:1388-1398. [PMID: 38270241 DOI: 10.1002/jbm.a.37678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Revised: 01/08/2024] [Accepted: 01/17/2024] [Indexed: 01/26/2024]
Abstract
Stem cell therapy and skin substitutes address the stalled healing of chronic wounds in order to promote wound closure; however, the high cost and regulatory hurdles of these treatments limit patient access. A low-cost method to induce bioactive healing has the potential to substantially improve patient care and prevent wound-induced limb loss. A previous study reported that bioactive factors derived from apoptotic-like mesenchymal stem cells (MSCs) demonstrated anti-inflammatory and proangiogenic effects and improved ischemic muscle regeneration. In this work, these MSC-derived bioactive factors were loaded into a hydrogel foam to harness immunomodulatory and angiogenic properties from MSC components to facilitate chronic wound healing without the high cost and translational challenges of cell therapies. After incorporation of bioactive factors, the hydrogel foam retained high absorbency, moisture retention, and target water vapor transmission rate. High loading efficiency was confirmed and release studies indicated that over 90% of loaded factors were released within 24 h. Ethylene oxide sterilization and 4-week storage did not affect the bioactive factor release profile or physical properties of the hydrogel foam dressing. Bioactivity retention of the released factors was also confirmed for as-sterilized, 4°C-stored, and -20°C-stored bioactive hydrogel foams as determined by relevant gene expression levels in treated pro-inflammatory (M1) macrophages. These results support the use of the bioactive dressings as an off-the-shelf product. Overall, this work reports a new method to achieve a first-line wound dressing with the potential to reduce persistent inflammation and promote angiogenesis in chronic wounds.
Collapse
Affiliation(s)
- Ziyang Lan
- Department of Biomedical Engineering, the University of Texas at Austin, Austin, Texas, USA
| | - Alan Fletcher
- Department of Biomedical Engineering, the University of Texas at Austin, Austin, Texas, USA
| | - Elizabeth C Bender
- Department of Biomedical Engineering, the University of Texas at Austin, Austin, Texas, USA
| | - Wenbai Huang
- School of Physical Education, Jinan University, Guangzhou, China
| | - Laura J Suggs
- Department of Biomedical Engineering, the University of Texas at Austin, Austin, Texas, USA
| | | |
Collapse
|
2
|
Gooran N, Kopra K. Fluorescence-Based Protein Stability Monitoring-A Review. Int J Mol Sci 2024; 25:1764. [PMID: 38339045 PMCID: PMC10855643 DOI: 10.3390/ijms25031764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2023] [Revised: 01/26/2024] [Accepted: 01/29/2024] [Indexed: 02/12/2024] Open
Abstract
Proteins are large biomolecules with a specific structure that is composed of one or more long amino acid chains. Correct protein structures are directly linked to their correct function, and many environmental factors can have either positive or negative effects on this structure. Thus, there is a clear need for methods enabling the study of proteins, their correct folding, and components affecting protein stability. There is a significant number of label-free methods to study protein stability. In this review, we provide a general overview of these methods, but the main focus is on fluorescence-based low-instrument and -expertise-demand techniques. Different aspects related to thermal shift assays (TSAs), also called differential scanning fluorimetry (DSF) or ThermoFluor, are introduced and compared to isothermal chemical denaturation (ICD). Finally, we discuss the challenges and comparative aspects related to these methods, as well as future opportunities and assay development directions.
Collapse
Affiliation(s)
| | - Kari Kopra
- Department of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland;
| |
Collapse
|
3
|
Xin X, Liu Y, Guo L, Wang H, Lu D, Chang Y, Wan M, Zhang Y, Shan Y, Zhang Q, Liu X, Gao F. Improvement of B Cell Responses by an HIV-1 Amphiphilic Polymer Nanovaccine. NANO LETTERS 2023; 23:4090-4094. [PMID: 37120753 DOI: 10.1021/acs.nanolett.3c01241] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
The human immunodeficiency virus (HIV) has infected over 84 million people since its discovery and is a huge threat to human health. While an HIV vaccine is urgently needed to curb this devastating pandemic, it has been notoriously difficult to develop, partly due to the extraordinary high level of genetic variation of HIV. We designed a new HIV-1 envelope glycoprotein nanoparticle (Env/NP) vaccine using amphiphilic polymers. The Env/NP vaccine induced more potent and broader neutralizing activities against multiple HIV-1 subtypes. Moreover, it elicits similar neutralizing antibody responses after the storage at -80 °C, 4 °C or room temperature post lyophilization. These results demonstrate that the new Env/NP vaccine not only improves the HIV vaccine immune responses but also is stable under different storage conditions. This new nanovaccine approach can readily apply to other protein-based vaccines.
Collapse
Affiliation(s)
- Xiaoqian Xin
- Institute of Molecular and Medical Virology, Key Laboratory of Ministry of Education for Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, Guangdong Province 510632, China
| | - Yifeng Liu
- Institute of Molecular and Medical Virology, Key Laboratory of Ministry of Education for Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, Guangdong Province 510632, China
| | - Lei Guo
- Institute of Molecular and Medical Virology, Key Laboratory of Ministry of Education for Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, Guangdong Province 510632, China
| | - Hui Wang
- Institute of Molecular and Medical Virology, Key Laboratory of Ministry of Education for Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, Guangdong Province 510632, China
| | - Daiqiang Lu
- Institute of Molecular and Medical Virology, Key Laboratory of Ministry of Education for Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, Guangdong Province 510632, China
| | - Yaotian Chang
- National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin Province 130012, China
| | - Mingming Wan
- National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin Province 130012, China
| | - Yong Zhang
- National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin Province 130012, China
| | - Yaming Shan
- National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin Province 130012, China
| | - Qiao Zhang
- Institute of Molecular and Medical Virology, Key Laboratory of Ministry of Education for Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, Guangdong Province 510632, China
| | - Xiaowen Liu
- Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, 220 Handan Road, Shanghai 200433, China
- Shanghai Engineering Research Center of Industrial Asymmetric Catalysis of Chiral Drugs, 220 Handan Road, Shanghai 200433, China
| | - Feng Gao
- Institute of Molecular and Medical Virology, Key Laboratory of Ministry of Education for Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, Guangdong Province 510632, China
| |
Collapse
|
4
|
Halder S, Jaiswal N, Koley H, Mahata N. Cloning, improved expression and purification of invasion plasmid antigen D (IpaD): an effector protein of enteroinvasive Escherichia coli (EIEC). Biotechnol Genet Eng Rev 2023:1-27. [PMID: 36871167 DOI: 10.1080/02648725.2023.2184027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2022] [Accepted: 02/15/2023] [Indexed: 03/06/2023]
Abstract
The widespread increase in broad-spectrum antimicrobial resistance is making it more difficult to treat gastrointestinal infections. Enteroinvasive Escherichia coli is a prominent etiological agent of bacillary dysentery, invading via the fecal-oral route and exerting virulence on the host via the type III secretion system. IpaD, a surface-exposed protein on the T3SS tip that is conserved among EIEC and Shigella, may serve as a broad immunogen for bacillary dysentery protection. For the first time, we present an effective framework for improving the expression level and yield of IpaD in the soluble fraction for easy recovery, as well as ideal storage conditions, which may aid in the development of new protein therapies for gastrointestinal infections in the future. To achieve this, uncharacterized full length IpaD gene from EIEC was cloned into pHis-TEV vector and induction parameters were optimized for enhanced expression in the soluble fraction. After affinity-chromatography based purification, 61% pure protein with a yield of 0.33 mg per litre of culture was obtained. The purified IpaD was retained its secondary structure with a prominent α-helical structure as well as functional activity during storage, at 4°C, -20°C and -80°C using 5% sucrose as cryoprotectants, which is a critical criterion for protein-based treatments.
Collapse
Affiliation(s)
- Sudeshna Halder
- Department of Biotechnology, National Institute of Technology Durgapur, Durgapur, India
| | - Namita Jaiswal
- Department of Biotechnology, National Institute of Technology Durgapur, Durgapur, India
| | - Hemanta Koley
- Department Bacteriology, National Institute of Cholera and Enteric Diseases, Kolkata, India
| | - Nibedita Mahata
- Department of Biotechnology, National Institute of Technology Durgapur, Durgapur, India
| |
Collapse
|
5
|
Zhao J, Yan W, Yang Y. DeepTP: A Deep Learning Model for Thermophilic Protein Prediction. Int J Mol Sci 2023; 24:ijms24032217. [PMID: 36768540 PMCID: PMC9917291 DOI: 10.3390/ijms24032217] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2022] [Revised: 01/19/2023] [Accepted: 01/19/2023] [Indexed: 01/26/2023] Open
Abstract
Thermophilic proteins have important value in the fields of biopharmaceuticals and enzyme engineering. Most existing thermophilic protein prediction models are based on traditional machine learning algorithms and do not fully utilize protein sequence information. To solve this problem, a deep learning model based on self-attention and multiple-channel feature fusion was proposed to predict thermophilic proteins, called DeepTP. First, a large new dataset consisting of 20,842 proteins was constructed. Second, a convolutional neural network and bidirectional long short-term memory network were used to extract the hidden features in protein sequences. Different weights were then assigned to features through self-attention, and finally, biological features were integrated to build a prediction model. In a performance comparison with existing methods, DeepTP had better performance and scalability in an independent balanced test set and validation set, with AUC values of 0.944 and 0.801, respectively. In the unbalanced test set, DeepTP had an average precision (AP) of 0.536. The tool is freely available.
Collapse
Affiliation(s)
- Jianjun Zhao
- School of Computer Science and Technology, Soochow University, Suzhou 215006, China
- Collaborative Innovation Center of Novel Software Technology and Industrialization, Nanjing 210000, China
| | - Wenying Yan
- Department of Bioinformatics, School of Biology and Basic Medical Sciences, Suzhou Medical College of Soochow University, Soochow University, Suzhou 215123, China
- Center for Systems Biology, Soochow University, Suzhou 215123, China
- Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, Suzhou 215123, China
- Correspondence: (W.Y.); (Y.Y.)
| | - Yang Yang
- School of Computer Science and Technology, Soochow University, Suzhou 215006, China
- Collaborative Innovation Center of Novel Software Technology and Industrialization, Nanjing 210000, China
- Correspondence: (W.Y.); (Y.Y.)
| |
Collapse
|
6
|
Determination of Conformational and Functional Stability of Potential Plague Vaccine Candidate in Formulation. Vaccines (Basel) 2022; 11:vaccines11010027. [PMID: 36679872 PMCID: PMC9865242 DOI: 10.3390/vaccines11010027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2022] [Revised: 12/07/2022] [Accepted: 12/18/2022] [Indexed: 12/24/2022] Open
Abstract
Generally, protein-based vaccines are available in liquid form and are highly susceptible to instability under elevated temperature changes including freezing conditions. There is a need to create a convenient formulation of protein/peptides that can be stored at ambient conditions without loss of activity or production of adverse effects. The efficiency of naturally occurring biocompatible polymer dextran in improving the shelf-life and biological activity of a highly thermally unstable plague vaccine candidate protein called Low Calcium Response V antigen (LcrV), which can be stored at room temperature (30 ± 2 °C), has been evaluated. To determine the preferential interactions with molecular-level insight into solvent-protein interactions, analytical techniques such asspectroscopy, particle size distribution, gel electrophoresis, microscopy, and thermal analysis have been performed along with the evaluation of humoral immune response, invivo. The analytical methods demonstrate the structural stability of the LcrV protein by expressing its interaction with the excipients in the formulation. The invivo studies elicited the biological activity of the formulated antigen with a significantly higher humoral immune response (p-value = 0.047) when compared to the native, adjuvanted antigen. We propose dextran as a potential biopolymer with its co-excipient sodium chloride (NaCl) to provide protein compactness, i.e., prevent protein unfolding by molecular crowding or masking mechanism using preferential hydrophobic interaction for up to three weeks at room temperature (30 ± 2 °C).
Collapse
|
7
|
Marco-Dufort B, Janczy JR, Hu T, Lütolf M, Gatti F, Wolf M, Woods A, Tetter S, Sridhar BV, Tibbitt MW. Thermal stabilization of diverse biologics using reversible hydrogels. SCIENCE ADVANCES 2022; 8:eabo0502. [PMID: 35930644 PMCID: PMC9355364 DOI: 10.1126/sciadv.abo0502] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/11/2022] [Accepted: 06/21/2022] [Indexed: 06/15/2023]
Abstract
Improving the thermal stability of biologics, including vaccines, is critical to reduce the economic costs and health risks associated with the cold chain. Here, we designed a versatile, safe, and easy-to-use reversible PEG-based hydrogel platform formed via dynamic covalent boronic ester cross-linking for the encapsulation, stabilization, and on-demand release of biologics. Using these reversible hydrogels, we thermally stabilized a wide range of biologics up to 65°C, including model enzymes, heat-sensitive clinical diagnostic enzymes (DNA gyrase and topoisomerase I), protein-based vaccines (H5N1 hemagglutinin), and whole viruses (adenovirus type 5). Our data support a generalized protection mechanism for the thermal stabilization of diverse biologics using direct encapsulation in reversible hydrogels. Furthermore, preliminary toxicology data suggest that the components of our hydrogel are safe for in vivo use. Our reversible hydrogel platform offers a simple material solution to mitigate the costs and risks associated with reliance on a continuous cold chain for biologic transport and storage.
Collapse
Affiliation(s)
- Bruno Marco-Dufort
- Macromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland
| | | | - Tianjing Hu
- Nanoly Bioscience Inc., Denver, CO 80231, USA
| | - Marco Lütolf
- Macromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland
| | - Francesco Gatti
- Macromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland
| | - Morris Wolf
- Macromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland
| | - Alex Woods
- Nanoly Bioscience Inc., Denver, CO 80231, USA
| | - Stephan Tetter
- Laboratory of Organic Chemistry, ETH Zurich, 8093 Zurich, Switzerland
| | | | - Mark W. Tibbitt
- Macromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland
| |
Collapse
|
8
|
Liu Y, Xu D, Liu Y, Zheng X, Zang J, Ye W, Zhao Y, He R, Ruan S, Zhang T, Dong H, Li Y, Li Y. Remotely boosting hyaluronidase activity to normalize the hypoxic immunosuppressive tumor microenvironment for photothermal immunotherapy. Biomaterials 2022; 284:121516. [DOI: 10.1016/j.biomaterials.2022.121516] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Revised: 04/03/2022] [Accepted: 04/05/2022] [Indexed: 12/20/2022]
|
9
|
Kumar R, Srivastava V, Baindara P, Ahmad A. Thermostable vaccines: an innovative concept in vaccine development. Expert Rev Vaccines 2022; 21:811-824. [PMID: 35285366 DOI: 10.1080/14760584.2022.2053678] [Citation(s) in RCA: 23] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
INTRODUCTION Vaccines represent one of the most common and safer ways of combating infectious diseases. Loss of potency owing to thermal denaturation or degradation of almost all the commercially available vaccines necessitates their storage, transportation, and final dissemination under refrigerated or deep-freeze conditions. However, maintenance of a continuous cold chain at every step raises the cost of vaccines significantly. A large number of life-saving vaccines are discarded before their application owing to exposure to sub-optimum temperatures. Therefore, there is a pressing need for the development of a thermostable vaccine with a long shelf life at ambient temperature. AREAS COVERED A literature search was performed to compile a list of different vaccines, along with their storage and handling conditions. Similarly, a separate list was prepared for different coronavirus vaccines which are in use against coronavirus disease 2019. A literature survey was also performed to look at different approaches undertaken globally to address the issue of the cold-chain problem. We emphasised the importance of yeast cells in the development of thermostable vaccines. In the end, we discussed why thermostable vaccines are required, not only in resource-poor settings in Asian and African countries but also for resource-rich settings in Europe and North America. EXPERT OPINION : Temperature change can severely impact the stability of various life-saving vaccines. Therefore, there is a pressing need for the development of thermostable vaccines with a long shelf life at ambient temperature.
Collapse
Affiliation(s)
- Ravinder Kumar
- Department of Obstetrics, Gynecology and Reproductive Science, University of California San Francisco, San Francisco 94143, California, USA
| | - Vartika Srivastava
- Department of Clinical Microbiology and Infectious Diseases, School of Pathology, University of Witwatersrand, Wits Medical School, Johannesburg 2193, South Africa
| | - Piyush Baindara
- Department of Molecular Microbiology and Immunology, University of Missouri, Columbia 65201, Missouri, USA
| | - Aijaz Ahmad
- Department of Clinical Microbiology and Infectious Diseases, School of Pathology, University of Witwatersrand, Wits Medical School, Johannesburg 2193, South Africa.,Infection Control, Charlotte Maxeke Johannesburg Academic Hospital, National Health Laboratory Service, Johannesburg, 2193, South Africa
| |
Collapse
|
10
|
Ki MR, Kim SH, Nguyen TKM, Son RG, Jun SH, Pack SP. BMP2-Mediated Silica Deposition: An Effective Strategy for Bone Mineralization. ACS Biomater Sci Eng 2022; 9:1823-1833. [PMID: 35090106 DOI: 10.1021/acsbiomaterials.1c01095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The combined use of an osteogenic factor, such as bone morphogenetic protein 2 (BMP2), with a bone scaffold was quite functional for the reconstruction of bone defects. Although many studies using BMP2 have been done, there is still a need to develop an efficient way to apply BMP2 in the bone scaffold. Here, we reported an interesting fact that BMP2 has a silica deposition ability in the presence of silicic acid and proposed that such an ability of BMP2 can effectively immobilize and transport itself by a kind of coprecipitation of BMP2 with a silica matrix. The presence of BMP2 in the resulting silica was proved by SEM and EDS and was visualized by FITC-labeled BMP2. The delivery efficacy of BMP2 of silica-entrapped BMP2 on osteoblast differentiation and mineralization using MC3T3 E1 preosteoblast cells was evaluated in vitro. The coprecipitated BMP2 with silica exhibited osteogenesis at a low concentration that was insufficient to give an osteoinductive signal as the free form. Expectedly, the silica-entrapped BMP2 exhibited thermal stability over free BMP2. When applied to bone graft substitution, e.g., hydroxyapatite granules (HA), silica-entrapped BMP 2 laden HA (BMP2@Si/HA) showed sustained BMP2 release, whereas free BMP2 adsorbed HA by a simple dipping method (BMP2/HA) displayed a burst release of BMP2 at an initial time. In the rat critical-size calvarial defect model, BMP2@Si/HA showed better bone regeneration than BMP2/HA by about 10%. The BMP2/silica hybrid deposited on a carrier surface via BMP2-mediated silica precipitation demonstrated an increase in the loading efficiency, a decrease in the burst release of BMP2, and an increase in bone regeneration. Taken together, the coprecipitated BMP2 with a silica matrix has the advantages of not only being able to immobilize BMP2 efficiently without compromising its function but also serving as a stable carrier for BMP2 delivery.
Collapse
Affiliation(s)
- Mi-Ran Ki
- Department of Biotechnology and Bioinformatics, Korea University, 2511 Sejong-ro, Sejong 30019, Korea.,Institution of Industrial Technology, Korea University, 2511 Sejong-ro, Sejong 30019, Korea
| | - Sung Ho Kim
- Department of Biotechnology and Bioinformatics, Korea University, 2511 Sejong-ro, Sejong 30019, Korea
| | - Thi Khoa My Nguyen
- Department of Biotechnology and Bioinformatics, Korea University, 2511 Sejong-ro, Sejong 30019, Korea
| | - Ryeo Gang Son
- Department of Biotechnology and Bioinformatics, Korea University, 2511 Sejong-ro, Sejong 30019, Korea
| | - Sang Ho Jun
- Departmtnt of Oral and Maxillofacial Surgery, Korea University Anam Hospital, 73 Goryeodae-ro, Seoul 02841, Korea
| | - Seung Pil Pack
- Department of Biotechnology and Bioinformatics, Korea University, 2511 Sejong-ro, Sejong 30019, Korea
| |
Collapse
|
11
|
Langellotto F, Dellacherie MO, Yeager C, Ijaz H, Yu J, Cheng C, Dimitrakakis N, Seiler BT, Gebre MS, Gilboa T, Johnson R, Storm N, Bardales S, Graveline A, White D, Tringides CM, Cartwright MJ, Doherty EJ, Honko A, Griffiths A, Barouch DH, Walt DR, Mooney DJ. A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens. Adv Healthc Mater 2021; 10:e2101370. [PMID: 34605223 PMCID: PMC8652677 DOI: 10.1002/adhm.202101370] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Revised: 09/07/2021] [Indexed: 12/14/2022]
Abstract
The coronavirus disease 2019 (COVID-19) pandemic demonstrates the importance of generating safe and efficacious vaccines that can be rapidly deployed against emerging pathogens. Subunit vaccines are considered among the safest, but proteins used in these typically lack strong immunogenicity, leading to poor immune responses. Here, a biomaterial COVID-19 vaccine based on a mesoporous silica rods (MSRs) platform is described. MSRs loaded with granulocyte-macrophage colony-stimulating factor (GM-CSF), the toll-like receptor 4 (TLR-4) agonist monophosphoryl lipid A (MPLA), and SARS-CoV-2 viral protein antigens slowly release their cargo and form subcutaneous scaffolds that locally recruit and activate antigen-presenting cells (APCs) for the generation of adaptive immunity. MSR-based vaccines generate robust and durable cellular and humoral responses against SARS-CoV-2 antigens, including the poorly immunogenic receptor binding domain (RBD) of the spike (S) protein. Persistent antibodies over the course of 8 months are found in all vaccine configurations tested and robust in vitro viral neutralization is observed both in a prime-boost and a single-dose regimen. These vaccines can be fully formulated ahead of time or stored lyophilized and reconstituted with an antigen mixture moments before injection, which can facilitate its rapid deployment against emerging SARS-CoV-2 variants or new pathogens. Together, the data show a promising COVID-19 vaccine candidate and a generally adaptable vaccine platform against infectious pathogens.
Collapse
Affiliation(s)
- Fernanda Langellotto
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
| | - Maxence O. Dellacherie
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
- Harvard John A. Paulson School of Engineering and Applied SciencesHarvard UniversityCambridgeMA02138USA
| | - Chyenne Yeager
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
| | - Hamza Ijaz
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
| | - Jingyou Yu
- Center for Virology and Vaccine ResearchBeth Israel Deaconess Medical CenterHarvard Medical SchoolBostonMA02115USA
| | - Chi‐An Cheng
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
- Department of PathologyBrigham and Women's HospitalBostonMA02115USA
- Harvard Medical SchoolBostonMA02115USA
| | - Nikolaos Dimitrakakis
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
| | - Benjamin T. Seiler
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
| | - Makda S. Gebre
- Center for Virology and Vaccine ResearchBeth Israel Deaconess Medical CenterHarvard Medical SchoolBostonMA02115USA
| | - Tal Gilboa
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
- Department of PathologyBrigham and Women's HospitalBostonMA02115USA
- Harvard Medical SchoolBostonMA02115USA
| | - Rebecca Johnson
- Department of MicrobiologyBoston University School of Medicine and National Emerging Infectious Diseases LaboratoriesBostonMA02118USA
| | - Nadia Storm
- Department of MicrobiologyBoston University School of Medicine and National Emerging Infectious Diseases LaboratoriesBostonMA02118USA
| | - Sarai Bardales
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
| | - Amanda Graveline
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
| | - Des White
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
| | - Christina M. Tringides
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
- Harvard Program in BiophysicsHarvard UniversityCambridgeMA02138USA
- Harvard–MIT Division in Health Sciences and TechnologyMassachusetts Institute of TechnologyCambridgeMA02139USA
| | - Mark J. Cartwright
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
| | - Edward J. Doherty
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
| | - Anna Honko
- Department of MicrobiologyBoston University School of Medicine and National Emerging Infectious Diseases LaboratoriesBostonMA02118USA
| | - Anthony Griffiths
- Department of MicrobiologyBoston University School of Medicine and National Emerging Infectious Diseases LaboratoriesBostonMA02118USA
| | - Dan H. Barouch
- Center for Virology and Vaccine ResearchBeth Israel Deaconess Medical CenterHarvard Medical SchoolBostonMA02115USA
- Ragon Institute of MGHMIT, and HarvardCambridgeMA02139USA
- Massachusetts Consortium on Pathogen ReadinessBostonMA02215USA
| | - David R. Walt
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
- Department of PathologyBrigham and Women's HospitalBostonMA02115USA
- Harvard Medical SchoolBostonMA02115USA
| | - David J. Mooney
- Wyss Institute for Biologically Inspired EngineeringHarvard UniversityBostonMA02115USA
- Harvard John A. Paulson School of Engineering and Applied SciencesHarvard UniversityCambridgeMA02138USA
| |
Collapse
|
12
|
Nahi O, Kulak AN, Kress T, Kim YY, Grendal OG, Duer MJ, Cayre OJ, Meldrum FC. Incorporation of nanogels within calcite single crystals for the storage, protection and controlled release of active compounds. Chem Sci 2021; 12:9839-9850. [PMID: 34349958 PMCID: PMC8293999 DOI: 10.1039/d1sc02991f] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2021] [Accepted: 06/14/2021] [Indexed: 11/21/2022] Open
Abstract
Nanocarriers have tremendous potential for the encapsulation, storage and delivery of active compounds. However, current formulations often employ open structures that achieve efficient loading of active agents, but that suffer undesired leakage and instability of the payloads over time. Here, a straightforward strategy that overcomes these issues is presented, in which protein nanogels are encapsulated within single crystals of calcite (CaCO3). Demonstrating our approach with bovine serum albumin (BSA) nanogels loaded with (bio)active compounds, including doxorubicin (a chemotherapeutic drug) and lysozyme (an antibacterial enzyme), we show that these nanogels can be occluded within calcite host crystals at levels of up to 45 vol%. Encapsulated within the dense mineral, the active compounds are stable against harsh conditions such as high temperature and pH, and controlled release can be triggered by a simple reduction of the pH. Comparisons with analogous systems - amorphous calcium carbonate, mesoporous vaterite (CaCO3) polycrystals, and calcite crystals containing polymer vesicles - demonstrate the superior encapsulation performance of the nanogel/calcite system. This opens the door to encapsulating a broad range of existing nanocarrier systems within single crystal hosts for the efficient storage, transport and controlled release of various active guest species.
Collapse
Affiliation(s)
- Ouassef Nahi
- School of Chemistry, University of Leeds Woodhouse Lane Leeds LS2 9JT UK
| | - Alexander N Kulak
- School of Chemistry, University of Leeds Woodhouse Lane Leeds LS2 9JT UK
| | - Thomas Kress
- Yusuf Hamied Department of Chemistry, University of Cambridge Lensfield Rd. Cambridge CB2 1EW UK
| | - Yi-Yeoun Kim
- School of Chemistry, University of Leeds Woodhouse Lane Leeds LS2 9JT UK
| | - Ola G Grendal
- The European Synchrotron Radiation Facility (ESRF) 71 Avenue des Martyrs 38000 Grenoble France
| | - Melinda J Duer
- Yusuf Hamied Department of Chemistry, University of Cambridge Lensfield Rd. Cambridge CB2 1EW UK
| | - Olivier J Cayre
- School of Chemical and Process Engineering, University of Leeds Woodhouse Lane Leeds LS2 9JT UK
| | - Fiona C Meldrum
- School of Chemistry, University of Leeds Woodhouse Lane Leeds LS2 9JT UK
| |
Collapse
|
13
|
Abu-Dief A, Alsehli M, Al-Enizi A, Nafady A. Recent Advances in Mesoporous Silica Nanoparticles for Targeted Drug Delivery applications. Curr Drug Deliv 2021; 19:436-450. [PMID: 34238185 DOI: 10.2174/1567201818666210708123007] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2021] [Revised: 03/15/2021] [Accepted: 04/17/2021] [Indexed: 11/22/2022]
Abstract
Nanotechnology provides the means to design and fabricate delivery vehicles capable of overcoming physiologically imposed obstacles and undesirable side effects of systemic drug delivery. This protocol allows maximal targeting effectiveness and therefore enhances therapeutic efficiency. In recent years, mesoporous silica nanoparticles (MSNPs) have sparked interest in the nanomedicine research community, particularly for their promising applications in cancer treatment. The intrinsic physio-chemical stability, facile functionalization, high surface area, low toxicity, and great loading capacity for a wide range of chemotherapeutic agents make MSNPs very appealing candidates for controllable drug delivery systems. Importantly, the peculiar nanostructures of MSNPs enabled them to serve as an effective drug, gene, protein, and antigen delivery vehicle for a variety of therapeutic regimens. For these reasons, in this review article, we underscore the recent progress in the design and synthesis of MSNPs and the parameters influencing their characteristic features and activities. In addition, the process of absorption, dissemination, and secretion by injection or oral management of MSNPs are also discussed, as they are key directions for the potential utilization of MSNPs. Factors influencing the in vivo fate of MSNPs will also be highlighted, with the main focus on particle size, morphology, porosity, surface functionality, and oxidation. Given that combining other functional materials with MSNPs may increase their biological compatibility, monitor drug discharge, or improve absorption by tumor cells coated MSNPs; these aspects are also covered and discussed herein.
Collapse
Affiliation(s)
- Ahmed Abu-Dief
- Chemistry Department, Faculty of Science, Taibah University, Madinah, Saudi Arabia
| | - Mosa Alsehli
- Chemistry Department, Faculty of Science, Taibah University, Madinah, Saudi Arabia
| | - Abdullah Al-Enizi
- Chemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
| | - Ayman Nafady
- Chemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
| |
Collapse
|
14
|
Ardila-Leal LD, Monterey-Gutiérrez PA, Poutou-Piñales RA, Quevedo-Hidalgo BE, Galindo JF, Pedroza-Rodríguez AM. Recombinant laccase rPOXA 1B real-time, accelerated and molecular dynamics stability study. BMC Biotechnol 2021; 21:37. [PMID: 34088291 PMCID: PMC8178886 DOI: 10.1186/s12896-021-00698-3] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2021] [Accepted: 05/24/2021] [Indexed: 12/28/2022] Open
Abstract
Background Laccases (EC 1.10.3.2) are multi-copper oxidoreductases with great biotechnological importance due to their high oxidative potential and utility for removing synthetic dyes, oxidizing phenolic compounds, and degrading pesticides, among others. Methods A real-time stability study (RTS) was conducted for a year, by using enzyme concentrates from 3 batches (L1, L3, and L4). For which, five temperatures 243.15, 277.15, 298.15, 303.15, 308.15, and 313.15 K were assayed. Using RTS data and the Arrhenius equation, we calculated the rPOXA 1B accelerated stability (AS). Molecular dynamics (MD) computational study results were very close to those obtained experimentally at four different temperatures 241, 278, 298, and 314 K. Results In the RTS, 101.16, 115.81, 75.23, 46.09, 5.81, and 4.83% of the relative enzyme activity were recovered, at respective assayed temperatures. AS study, showed that rPOXA 1B is stable at 240.98 ± 5.38, 277.40 ± 1.32 or 297.53 ± 3.88 K; with t1/2 values of 230.8, 46.2, and 12.6 months, respectively. Kinetic and thermodynamic parameters supported the high stability of rPOXA 1B, with an Ed value of 41.40 KJ mol− 1, a low variation of KM and Vmax, at 240.98 ± 5.38, and 297.53 ± 3.88 K, and ∆G values showing deactivation reaction does not occur. The MD indicates that fluctuations in loop, coils or loops with hydrophilic or intermediate polarity amino acids as well as in some residues of POXA 1B 3D structure, increases with temperature; changing from three fluctuating residues at 278 K to six residues at 298 K, and nine residues at 314 K. Conclusions Laccase rPOXA 1B demonstrated experimentally and computationally to be a stable enzyme, with t1/2 of 230.8, 46.2 or 12.6 months, if it is preserved impure without preservatives at temperatures of 240.98 ± 5.38, 277.40 ± 1.32 or 297.53 ± 3.88 K respectively; this study could be of great utility for large scale producers. Supplementary Information The online version contains supplementary material available at 10.1186/s12896-021-00698-3.
Collapse
Affiliation(s)
- Leidy D Ardila-Leal
- Departamento de Microbiología. Facultad de Ciencias. Pontificia Universidad Javeriana (PUJ). Bogotá, Laboratorio de Biotecnología Molecular, Grupo de Biotecnología Ambiental e Industrial (GBAI), Bogotá, D.C, Colombia
| | - Pedro A Monterey-Gutiérrez
- Vicerrectoría Académica. Universidad Antonio Nariño, Programa de Maestría y Doctorado en Educación Matemática, Bogotá, D.C, Colombia
| | - Raúl A Poutou-Piñales
- Departamento de Microbiología. Facultad de Ciencias. Pontificia Universidad Javeriana (PUJ). Bogotá, Laboratorio de Biotecnología Molecular, Grupo de Biotecnología Ambiental e Industrial (GBAI), Bogotá, D.C, Colombia.
| | - Balkys E Quevedo-Hidalgo
- Departamento de Microbiología. Facultad de Ciencias. Pontificia Universidad Javeriana (PUJ), Laboratorio de Biotecnología Aplicada, Grupo de Biotecnología Ambiental e Industrial (GBAI), Bogotá, D.C, Colombia.
| | - Johan F Galindo
- Departamento de Química, Universidad Nacional de Colombia, Bogotá, D.C, Colombia.
| | - Aura M Pedroza-Rodríguez
- Departamento de Microbiología. Facultad de Ciencias. Pontificia Universidad Javeriana (PUJ). Bogotá, Laboratorio de Microbiología Ambiental y de Suelos, Grupo de Biotecnología Ambiental e Industrial (GBAI), Bogotá, D.C, Colombia
| |
Collapse
|
15
|
Boylan J, Chauhan R, Koneru K, Bansal M, Kalbfleisch T, Potnis CS, Hartline K, Keynton RS, Gupta G. Bio-CaRGOS: capture and release gels for optimized storage of hemoglobin. RSC Adv 2021; 11:13034-13039. [PMID: 35423878 PMCID: PMC8697545 DOI: 10.1039/d1ra00987g] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2021] [Accepted: 03/12/2021] [Indexed: 11/21/2022] Open
Abstract
A schematic of encapsulation of hemoglobin within Bio:CaRGOS formulations is summarized in the graphic, demonstrating sol–gel encapsulation as a method to stabilize hemoglobin, followed by an efficient hemoglobin release using polyethylene glycol (PEG).
Collapse
Affiliation(s)
- Jack Boylan
- Department of Chemical Engineering
- University of Louisville
- Louisville
- USA
| | - Rajat Chauhan
- Department of Bioengineering
- University of Louisville
- Louisville
- USA
| | - Kavya Koneru
- Department of Chemical Engineering
- University of Louisville
- Louisville
- USA
| | | | | | | | | | | | - Gautam Gupta
- Department of Chemical Engineering
- University of Louisville
- Louisville
- USA
| |
Collapse
|
16
|
Montoya NA, Barr KE, Morales SV, Umana JE, Ny C, Roth RE, Reyes EJ, Kirchhoff BC, Hartman ER, Higgins LL, Nichol KM, Morais ARC, Allgeier AM, Gao P, Picking WD, Corbin DR, Shiflett MB. Protein Stabilization and Delivery: A Case Study of Invasion Plasmid Antigen D Adsorbed on Porous Silica. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2020; 36:14276-14287. [PMID: 33095588 DOI: 10.1021/acs.langmuir.0c02400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Approximately half of all vaccines produced annually are wasted because effectivity is dependent on protein structure and heat exposure disrupts the intermolecular interactions needed to maintain the structure. Thus, most vaccines require a temperature-controlled supply chain to minimize waste. A more sustainable technology was developed via the adsorption of invasion plasmid antigen D (IpaD) onto mesoporous silica, improving the thermal stability of this protein-based therapeutic. Seven silicas were characterized to determine the effects of pore diameter, pore volume, and surface area on protein adsorption. The silica-IpaD complex was then heated above the IpaD denaturing temperature and N,N-dimethyldodecylamine N-oxide was used to remove IpaD from the silica. Circular dichroism confirmed that the adsorbed IpaD after the heat treatment maintained a native secondary structure rich in α-helix content. In contrast, the unprotected IpaD after heat treatment lost its secondary structure. Isotherms using Langmuir, Freundlich, and Temkin models demonstrated that the adsorption of IpaD onto silicas is best fit by the Langmuir model. If pores are less than 15 nm, adsorption is negligible. If the pores are between 15 and 25 nm, then monolayer coverage is achieved and IpaD is protected from thermal denaturing. If pores are larger than 25 nm, the adsorption is a multilayer coverage and it is easier to remove the protein from the silica because of a less-developed hydrogen bond network. This case study provides strong evidence that IpaD is thermally stabilized via adsorption on mesoporous silica with the proper range of pore sizes.
Collapse
Affiliation(s)
- Nicole A Montoya
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
| | - Kaylee E Barr
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
| | - Simon Velasquez Morales
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
| | - Jorge E Umana
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
| | - Channary Ny
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
| | - Rhianna E Roth
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
| | - Edward J Reyes
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
| | - Brian C Kirchhoff
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
| | - Eric R Hartman
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
| | - Lillian L Higgins
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
| | - Kalena M Nichol
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
| | - Ana Rita C Morais
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
| | - Alan M Allgeier
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
- Center for Environmentally Beneficial Catalysis, University of Kansas, 1501 Wakarusa Dr, Lawrence, Kansas 66047, United States
| | - Phillip Gao
- Shankel Structural Biology Center, University of Kansas, 2034 Becker Drive, Lawrence, Kansas 66047, United States
| | - William D Picking
- Department of Pharmaceutical Chemistry, University of Kansas, 2093 Constant Avenue, Lawrence, Kansas 66047, United States
| | - David R Corbin
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
- Center for Environmentally Beneficial Catalysis, University of Kansas, 1501 Wakarusa Dr, Lawrence, Kansas 66047, United States
| | - Mark B Shiflett
- Institute for Sustainable Engineering, Department of Chemical and Petroleum Engineering, University of Kansas, 1530 W. 15th Street, Lawrence, Kansas 66045, United States
- Center for Environmentally Beneficial Catalysis, University of Kansas, 1501 Wakarusa Dr, Lawrence, Kansas 66047, United States
| |
Collapse
|
17
|
Bui-Le L, Brogan APS, Hallett JP. Solvent-free liquid avidin as a step toward cold chain elimination. Biotechnol Bioeng 2020; 118:592-600. [PMID: 33090452 DOI: 10.1002/bit.27587] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2020] [Revised: 09/21/2020] [Accepted: 09/27/2020] [Indexed: 11/10/2022]
Abstract
The temperature sensitivity of vaccines and therapeutic proteins forces the distribution of life-saving treatments to rely heavily on the temperature-controlled (usually 2-8°C) supply and distribution network known as the cold chain. Here, using avidin as a model, we demonstrate how surface engineering could significantly increase the thermal stability of therapeutic proteins. A combination of spectroscopic (Fourier transform infrared, circular dichroism, and ultraviolet-visible) and scattering techniques (dynamic light scattering, small-angle, and wide-angle X-ray scattering) were deployed to probe the activity, structure, and stability of the model protein. Temperature-dependent synchrotron radiation circular dichroism spectroscopy was used to demonstrate a significant increase in thermal stability, with a half denaturation temperature of 139.0°C and reversible unfolding with modified avidin returning to a 90% folded state when heated to temperatures below 100°C. Accelerated aging studies revealed that modified avidin retained its secondary structure after storage at 40°C for 56 days, equivalent to 160 days at 25°C. Furthermore, binding studies with multiple ligands revealed that the binding site remained functional after modification. As a result, this approach has potential as a storage technology for therapeutic proteins and the elimination of the cold chain, enabling the dissemination of life-saving vaccines worldwide.
Collapse
Affiliation(s)
- Liem Bui-Le
- Department of Chemical Engineering, Imperial College London, London, UK
| | - Alex P S Brogan
- Department of Chemistry, King's College London, Britannia House, London, UK
| | - Jason P Hallett
- Department of Chemical Engineering, Imperial College London, London, UK
| |
Collapse
|
18
|
Miotto M, Olimpieri PP, Di Rienzo L, Ambrosetti F, Corsi P, Lepore R, Tartaglia GG, Milanetti E. Insights on protein thermal stability: a graph representation of molecular interactions. Bioinformatics 2020; 35:2569-2577. [PMID: 30535291 PMCID: PMC6662296 DOI: 10.1093/bioinformatics/bty1011] [Citation(s) in RCA: 55] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2018] [Revised: 10/29/2018] [Accepted: 12/07/2018] [Indexed: 11/14/2022] Open
Abstract
Motivation Understanding the molecular mechanisms of thermal stability is a challenge in protein biology. Indeed, knowing the temperature at which proteins are stable has important theoretical implications, which are intimately linked with properties of the native fold, and a wide range of potential applications from drug design to the optimization of enzyme activity. Results Here, we present a novel graph-theoretical framework to assess thermal stability based on the structure without any a priori information. In this approach we describe proteins as energy-weighted graphs and compare them using ensembles of interaction networks. Investigating the position of specific interactions within the 3D native structure, we developed a parameter-free network descriptor that permits to distinguish thermostable and mesostable proteins with an accuracy of 76% and area under the receiver operating characteristic curve of 78%. Availability and implementation Code is available upon request to edoardo.milanetti@uniroma1.it Supplementary information Supplementary data are available at Bioinformatics online.
Collapse
Affiliation(s)
- Mattia Miotto
- Department of Physics, Sapienza University, Piazzale Aldo Moro 5, Rome, Italy.,Center for Life Nano Science@Sapienza, Instituto Italiano di Tecnologia, Viale Regina Elena, 291 Roma (RM), Italy.,Soft and Living Matter Laboratory, Institute of Nanotechnology, Consiglio Nazionale delle Ricerche, Rome, Italy
| | | | - Lorenzo Di Rienzo
- Department of Physics, Sapienza University, Piazzale Aldo Moro 5, Rome, Italy
| | - Francesco Ambrosetti
- Department of Physics, Sapienza University, Piazzale Aldo Moro 5, Rome, Italy.,Bijvoet Center for Biomolecular Research, Faculty of Science - Chemistry, Utrecht University, Padualaan 8, Utrecht, the Netherlands
| | - Pietro Corsi
- Department of Science, Università degli Studi "Roma Tre", via della Vasca Navale 84, Rome, Italy
| | - Rosalba Lepore
- Biozentrum, University of Basel, Klingelbergstrasse 50-70, CH-4056 Basel, Switzerland.,SIB Swiss Institute of Bioinformatics, Biozentrum, University of Basel, Klingelbergstrasse 50-70, CH-4056 Basel, Switzerland
| | - Gian Gaetano Tartaglia
- Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader St. 88, Barcelona, Spain.,Institucio' Catalana de Recerca i Estudis Avancats (ICREA), 23 Passeig Lluìs Companys, Barcelona, Spain.,Department of Biology and Biotechnology, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome, Italy
| | - Edoardo Milanetti
- Department of Physics, Sapienza University, Piazzale Aldo Moro 5, Rome, Italy.,Center for Life Nano Science@Sapienza, Instituto Italiano di Tecnologia, Viale Regina Elena, 291 Roma (RM), Italy
| |
Collapse
|
19
|
Ensilicated tetanus antigen retains immunogenicity: in vivo study and time-resolved SAXS characterization. Sci Rep 2020; 10:9243. [PMID: 32513957 PMCID: PMC7280242 DOI: 10.1038/s41598-020-65876-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2019] [Accepted: 03/30/2020] [Indexed: 11/21/2022] Open
Abstract
Our recently developed ensilication approach can physically stabilize proteins in silica without use of a pre-formed particle matrix. Stabilisation is done by tailor fitting individual proteins with a silica coat using a modified sol-gel process. Biopharmaceuticals, e.g. liquid-formulated vaccines with adjuvants, frequently have poor thermal stability; heating and/or freezing impairs their potency. As a result, there is an increase in the prevalence of vaccine-preventable diseases in low-income countries even when there are means to combat them. One of the root causes lies in the problematic vaccine ‘cold chain’ distribution. We believe that ensilication can improve vaccine availability by enabling transportation without refrigeration. Here, we show that ensilication stabilizes tetanus toxin C fragment (TTCF), a component of the tetanus toxoid present in the diphtheria, tetanus and pertussis (DTP) vaccine. Experimental in vivo immunization data show that the ensilicated material can be stored, transported at ambient temperatures, and even heat-treated without compromising the immunogenic properties of TTCF. To further our understanding of the ensilication process and its protective effect on proteins, we have also studied the formation of TTCF-silica nanoparticles via time-resolved Small Angle X-ray Scattering (SAXS). Our results reveal ensilication to be a staged diffusion-limited cluster aggregation (DLCA) type reaction. An early stage (tens of seconds) in which individual proteins are coated with silica is followed by a subsequent stage (several minutes) in which the protein-containing silica nanoparticles aggregate into larger clusters. Our results suggest that we could utilize this technology for vaccines, therapeutics or other biopharmaceuticals that are not compatible with lyophilization.
Collapse
|
20
|
Development of Silica-Immobilized Vaccines for Improving Thermo-Tolerance and Shelf-Life. Kans J Med 2020; 13:6-9. [PMID: 32256968 PMCID: PMC7107000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2020] [Accepted: 02/10/2020] [Indexed: 11/16/2022] Open
Abstract
INTRODUCTION It is estimated that 50% of vaccines produced annually are wasted because effectivity is dependent on protein structure and heat exposure disrupts the intermolecular interactions that maintain this structure. Since 90% of vaccines require a temperature-controlled supply chain, it is necessary to create a cold chain system to minimize vaccine waste. We have developed a more sustainable technology via the adsorption of Invasion Plasmid Antigen D (IpaD) onto mesoporous silica gels, improving the thermal stability of protein-based therapeutics. METHODS The solution depletion method using UV-Vis was utilized to study the adsorption of IpaD onto silica gels. The silica-IpaD complex is heated above the denaturing temperature of the protein and then the IpaD is removed using N,N-Dimethyldodecylamine N-oxide (LDAO) and their secondary structure is tested using circular dichroism (CD). RESULTS Pore diameter, pore volume and surface area were characterized for seven different silica gels. Silica gels designated as 6389, 6378, and 6375 had an adsorption percentage above 95% at pore volumes of 2.2, 2.8 and 3.8 cm3 mg-1, respectively. CD analyses confirmed that the adsorbed IpaD after the heat treatment displayed a similar "W" shape CD signal as the native IpaD, indicating the conservation of α-helices. In contrast, the unprotected IpaD after being exposed to high temperature shows a flat CD signal, demonstrating the loss of secondary structure. CONCLUSION We have successfully increased the thermo-tolerance for IpaD using mesoporous silica and continue to further optimize mesoporous silica's physiochemical properties to improve adsorption and desorption yields.
Collapse
|
21
|
Doekhie A, Slade MN, Cliff L, Weaver L, Castaing R, Paulin J, Chen YC, Edler KJ, Koumanov F, Marchbank KJ, van den Elsen JMH, Sartbaeva A. Thermal resilience of ensilicated lysozyme via calorimetric and in vivo analysis. RSC Adv 2020; 10:29789-29796. [PMID: 35518265 PMCID: PMC9056174 DOI: 10.1039/d0ra06412b] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2020] [Accepted: 08/04/2020] [Indexed: 12/02/2022] Open
Abstract
Ensilication is a novel method of protein thermal stabilisation using silica. It uses a modified sol–gel process which tailor fits a protective silica shell around the solvent accessible protein surface. This, electrostatically attached, shell has been found to protect the protein against thermal influences and retains its native structure and function after release. Here, we report the calorimetric analysis of an ensilicated model protein, hen egg-white lysozyme (HEWL) under several ensilication conditions. DSC, TGA-DTA-MS, CD, were used to determine unfolding temperatures of native, released and ensilicated lysozyme to verify the thermal resilience of the ensilicated material. Our findings indicate that ensilication protects against thermal fluctuations even at low concentrations of silica used for ensilication. Secondly, the thermal stabilisation is comparable to lyophilisation, and in some cases is even greater than lyophilisation. Additionally, we performed a mouse in vivo study using lysozyme to demonstrate the antigenic retention over long-term storage. The results suggest that protein is confined within the ensilicated material, and thus is unable to unfold and denature but is still functional after long-term storage. Ensilication is a novel method of protein thermal stabilisation using silica. It uses a modified sol–gel process which tailor fits a protective silica shell around the protein to enable room temperature storage of biopharmaceuticals.![]()
Collapse
Affiliation(s)
- A. Doekhie
- Department of Chemistry
- University of Bath
- Bath
- UK
| | - M. N. Slade
- Department of Chemistry
- University of Bath
- Bath
- UK
| | - L. Cliff
- Department of Chemistry
- University of Bath
- Bath
- UK
| | - L. Weaver
- Department of Chemistry
- University of Bath
- Bath
- UK
| | - R. Castaing
- Material and Chemical Characterisation Facility
- University of Bath
- Bath
- UK
| | - J. Paulin
- The Medical School
- Framlington Place
- Newcastle University
- Newcastle upon Tyne
- UK
| | - Y.-C. Chen
- Department of Chemistry
- University of Bath
- Bath
- UK
| | - K. J. Edler
- Department of Chemistry
- University of Bath
- Bath
- UK
| | - F. Koumanov
- Department for Health
- University of Bath
- Bath
- UK
| | - K. J. Marchbank
- The Medical School
- Framlington Place
- Newcastle University
- Newcastle upon Tyne
- UK
| | | | | |
Collapse
|
22
|
Wahid AA, Doekhie A, Sartbaeva A, van den Elsen JMH. Ensilication Improves the Thermal Stability of the Tuberculosis Antigen Ag85b and an Sbi-Ag85b Vaccine Conjugate. Sci Rep 2019; 9:11409. [PMID: 31391509 PMCID: PMC6685958 DOI: 10.1038/s41598-019-47657-9] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Accepted: 07/16/2019] [Indexed: 02/03/2023] Open
Abstract
There is an urgent need for the development of vaccine thermostabilisation methodologies as the maintenance of a continuous and reliable cold chain remains a major hurdle to the global distribution of safe and effective vaccines. Ensilication, a method that encases proteins in a resistant silica cage has been shown to physically prevent the thermal denaturation of a number of model proteins. In this study we investigate the utility of this promising approach in improving the thermal stability of antigens and vaccine conjugates highly relevant to the development of candidate tuberculosis vaccines, including antigen 85b conjugated with the Staphylococcus aureus-protein based adjuvant Sbi. Here we analyse the sensitivity of these constructs to thermal denaturation and demonstrate for the first time the benefits of ensilication in conferring these vaccine-relevant proteins with protection against temperature-induced loss of structure and function without the need for refrigeration. Our results reveal the potential of ensilication in facilitating the storage and transport of vaccines at ambient temperatures in the future and therefore in delivering life-saving vaccines globally, and in particular to remote areas of developing countries where disease rates are often highest.
Collapse
Affiliation(s)
- A A Wahid
- Department of Biology and Biochemistry, University of Bath, Bath, UK
| | - A Doekhie
- Department of Chemistry, University of Bath, Bath, UK
| | - A Sartbaeva
- Department of Chemistry, University of Bath, Bath, UK.
| | | |
Collapse
|
23
|
Jafari S, Derakhshankhah H, Alaei L, Fattahi A, Varnamkhasti BS, Saboury AA. Mesoporous silica nanoparticles for therapeutic/diagnostic applications. Biomed Pharmacother 2018; 109:1100-1111. [PMID: 30551360 DOI: 10.1016/j.biopha.2018.10.167] [Citation(s) in RCA: 246] [Impact Index Per Article: 41.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2018] [Revised: 10/26/2018] [Accepted: 10/26/2018] [Indexed: 12/17/2022] Open
Abstract
Based on unique intrinsic properties of mesoporous silica nanoparticles (MSNs) such as high surface area, large pore size, good biocompatibility and biodegradability, stable aqueous dispersion, they have received much attention in the recent decades for their applications as a promising platform in the biomedicine field. These porous structures possess a pore size ranging from 2 to 50 nm which make them excellent candidates for various biomedical applications. Herein, at first we described the common approaches of cargo loading and release processes from MSNs. Then, the intracellular uptake, safety and cytotoxicity aspects of MSNs are discussed as well. This review also highlights the most recent advances in the biomedical applications of MSNs, including 1) MSNs-based carriers, 2) MSNs as bioimaging agents, 3) MSNs-based biosensors, 4) MSNs as therapeutic agents (photodynamic therapy), 5) MSN based quantum dots, 6) MSNs as platforms for upconverting nanoparticles, and 6) MSNs in tissue engineering.
Collapse
Affiliation(s)
- Samira Jafari
- Pharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Hossein Derakhshankhah
- Pharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
| | - Loghman Alaei
- Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
| | - Ali Fattahi
- Pharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Behrang Shiri Varnamkhasti
- Pharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Ali Akbar Saboury
- Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
| |
Collapse
|